You just read:

Pharmaleads Reports Positive Ocular Pain Results with PL265, a Novel Dual Enkephalinase Inhibitor (DENKI), at the ARVO 2017 Annual Meeting

News provided by

Pharmaleads

May 12, 2017, 02:00 ET